According to Athersys's latest financial reports and stock price the company's current number of shares outstanding is 24,492,000. At the end of 2023 the company had 24,492,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 24.49 M | 55.91% |
2022 | 15.7 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 9,728.52% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 22,956.51% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 2,084.39% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 10,136.81% | ๐ซ๐ท France |
Merck MRK | 2,554,166,667 | 10,328.58% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,023,000,000 | 8,159.84% | ๐บ๐ธ USA |
Moderna
MRNA | 381,000,000 | 1,455.61% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | 56,662,000 | 131.35% | ๐บ๐ธ USA |